COVID-19 Vaccine Responses in PIDD Subjects

Clinical trial NCT05321407 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05321407
Sponsor: Duke University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

X-linked Agammaglobulinemia XLA Primary Immune Deficiency CVID Common Variable Immunodeficiency Primary Antibody Deficiencies Secondary Hypogammaglobulinemia

Start date: 2021-09-30
Primary completion: 2026-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.